Allergic rhinitis: Impact of the disease and considerations for management

Medical Clinics of North America

Volumn 90, Issue 1, 2006, Pages 17-38

  Greiner, Alexander N ^a,b  

^a ALLERGY AND ASTHMA MEDICAL GROUP AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; AZELASTINE; BECLOMETASONE DIPROPIONATE; BROMPHENIRAMINE; BUDESONIDE; CETIRIZINE; CHLORPHENIRAMINE; CHLORPHENIRAMINE MALEATE; CLEMASTINE; CORTICOSTEROID; CYPROHEPTADINE; DECONGESTIVE AGENT; DESLORATADINE; DIPHENHYDRAMINE; DOXEPIN; EBASTINE; FEXOFENADINE; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; IMMUNOGLOBULIN E; IMMUNOMODULATING AGENT; LORATADINE; MEPYRAMINE; MIZOLASTINE; MOMETASONE FUROATE; PROMETHAZINE; TRIAMCINOLONE ACETONIDE; TRIPELENNAMINE; TRIPROLIDINE; UNINDEXED DRUG;

ALLERGIC CONJUNCTIVITIS; ALLERGIC RHINITIS; ASTHMA; ATOPY; ATROPHY; BITTER TASTE; CANDIDIASIS; COMORBIDITY; COST; DISEASE SEVERITY; DRY NOSE; EPISTAXIS; HUMAN; IMMUNE SYSTEM; IMMUNOTHERAPY; INFLAMMATION; NASAL BURNING; NASAL STINGING; NOSE CONGESTION; NOSE IRRITATION; NOSE MUCOSA; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; REVIEW; RHINORRHEA; RHINOSINUSITIS; RISK FACTOR; SECRETORY OTITIS MEDIA; SEDATION; SIDE EFFECT; SNEEZING; TASTE DISORDER; VASOMOTOR RHINITIS;

ANTI-INFLAMMATORY AGENTS; COST OF ILLNESS; DESENSITIZATION, IMMUNOLOGIC; HISTAMINE H1 ANTAGONISTS; HUMANS; IMMUNOLOGIC FACTORS; LEUKOTRIENE ANTAGONISTS; QUALITY OF LIFE; RESPIRATORY SYSTEM AGENTS; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL;

EID: 27944468256     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2005.08.011     Document Type: Review

References (97)

1. J. Bousquet, P.B. van Cauwenberge, and N. Khaltaev Allergic rhinitis and its impact on asthma. ARIA workshop report J Allergy Clin Immunol 108 2001 S147
2. R.G. Hamilton, and N. Franklin Adkinson Jr. In vitro assays for the diagnosis of IgE-mediated disorders J Allergy Clin Immunol 114 2 2004 213 225
3. M. Ingall, J. Glaser, and R.S. Meltzer Allergic rhinitis in early infancy. Review of the literature and report of a case in a newborn Pediatrics 35 1965 108 112
4. R.A. Nathan, E.O. Meltzer, and J.C. Selner Prevalence of allergic rhinitis in the United States J Allergy Clin Immunol 99 1997 S808 S814
5. A.L. Wright, C.J. Holberg, and F.D. Martinez Epidemiology of physician-diagnosed allergic rhinitis in childhood Pediatrics 94 6 Pt 1 1994 895 901
6. D.P. Skoner Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis J Allergy Clin Immunol 108 Suppl 1 2001 S2 S8
7. M.S. Dykewicz, S. Fineman, and R. Nicklas Joint task force algorithm and annotations for diagnosis and management of rhinitis Ann Allergy Asthma Immunol 81 5 Pt 2 1998 469 473
8. C. Ober Susceptibility genes in asthma and allergy Curr Allergy Asthma Rep 1 2 2001 174 179
9. R. Evans Epidemiology and natural history of asthma, allergic rhinitis, and atopic dermatitis (eczema) E. Middleton C. Reed E. Ellis Allergy: principles and practice 4th edition 1993 Mosby St. Louis (MO) 1109 1136
10. M.K. Tulic, J.L. Wale, and P.G. Holt Modification of the inflammatory response to allergen challenge after exposure to bacterial lipopolysaccharide Am J Respir Cell Mol Biol 22 5 2000 604 612
11. E. Von Mutius, and F.D. Martinez Natural history, development, and prevention of allergic disease in childhood N.F. Adkinson Jr. J.W. Yunginger W.W. Busse Middleton's allergy: principles and practice 4th edition 2003 Mosby St. Louis (MO) 1169 1174
12. B. Leynaert, J. Bousquet, and C. Neukirch Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey J Allergy Clin Immunol 104 2 Pt 1 1999 301 304
13. B. Leynaert, R. Liard, and J. Bousquet Lessons from the French part of the European community respiratory health survey (ECRHS) Allergy Clin Immunol Int: S World Allergy Org 11 1999 218 225
14. Centers for Disease Control and Prevention. Current asthma prevalence 2002. Available at: http://www.cdc.gov. Accessed February 12, 2005.
15. G.J. Braunstahl, A. Kleinjan, and S.E. Overbeek Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients Am J Respir Crit Care Med 161 2000 2051 2057
16. G.J. Braunstahl, S.E. Overbeek, and A. Kleinjan Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways J Allergy Clin Immunol 107 2001 469 476
17. S.H. Shin, J.U. Ponikau, and D.A. Sherris Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi J Allergy Clin Immunol 114 6 2004 1369 1375
18. L.B. Bielory Allergic and immunologic disorders of the eye. Part II: Ocular allergy J Allergy Clin Immunol 106 2001 1019 1032
19. H. Chen, P.P. Katz, and M.D. Eisner Health-related quality of life in adult rhinitis: the role of perceived control of disease J Allergy Clin Immunol 114 4 2004 845 850
20. J. Bousquet, M. Bullinger, and C. Fayol Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire J Allergy Clin Immunol 94 2 Pt 1 1994 182 188
21. J. Bousquet, J. Knani, and H. Dhivert Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire Am J Respir Crit Care Med 149 1994 371 375
22. B. Leynaert, C. Neukirch, and R. Liard Quality of life in allergic rhinitis and asthma. A population-based study of young adults Am J Respir Crit Care Med 162 4 Pt 1 2000 1391 1396
23. P.D. Blanc, L. Trupin, and M. Eisner The work impact of asthma and rhinitis: findings from a population-based survey J Clin Epidemiol 54 6 2001 610 618
24. I. Terreehorst, E. Hak, and A.J. Oosting Evaluation of impermeable covers for bedding in patients with allergic rhinitis N Engl J Med 349 2003 237 246
25. R.E. Reisman, P.M. Mauriello, and G.B. Davis A double-blind study of the effectiveness of a high-efficiency particulate air (HEPA) filter in the treatment of patients with perennial allergic rhinitis and asthma J Allergy Clin Immunol 85 6 1990 1050 1057
26. R. Codina, R.F. Lockey, and R. Diwadkar Disodium octaborate tetrahydrate (DOT) application and vacuum cleaning, a combined strategy to control house dust mites Allergy 58 4 2003 318 324
27. S.J. Hyndman, L.M. Vickers, and T. Htut A randomized trial of dehumidification in the control of house dust mite Clin Exp Allergy 30 8 2000 1172 1180
28. C.V. Klucka, D.R. Ownby, and J. Green Cat shedding of Fel d I is not reduced by washings, Allerpet-C spray, or acepromazine J Allergy Clin Immunol 95 6 1995 1164 1171
29. R.A. Wood, E.F. Johnson, and M.L. Van Natta A placebo-controlled trial of a HEPA air cleaner in the treatment of cat allergy Am J Respir Crit Care Med 158 1 1998 115 120
30. R.A. Wood, P.A. Eggleston, and C. Rand Cockroach allergen abatement with extermination and sodium hypochlorite cleaning in inner-city homes Ann Allergy Asthma Immunol 87 1 2001 60 64
31. W.T. Watson, A.B. Becker, and F.E. Simons Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness J Allergy Clin Immunol 91 1993 97 101
32. A. Fosi, A. Pelucchi, and G. Gherson Once daily intranasal fluticasone propionate (200 μg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis J Allergy Clin Immunol 98 1996 274 282
33. F. Orhan, B.E. Sekerel, and G. Adalioglu Effect of nasal triamcinolone acetonide on seasonal variations of bronchial hyperresponsiveness and bronchial inflammation in nonasthmatic children with seasonal allergic rhinitis Ann Allergy Asthma Immunol 92 4 2004 438 445
34. B. Pedersen, R. Dahl, and N. Lindqvist Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma Allergy 45 1990 451 456
35. R.J. Adams, A.L. Fuhlbrigge, and J.A. Finkelstein Intranasal steroids and the risk of emergency department visits for asthma J Allergy Clin Immunol 109 4 2002 636 642
36. B.F. Luisi, W.X. Xu, and Z. Otwinoeski Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA Nature 352 1991 497 505
37. M.I. Diamond, J.N. Miner, and S.K. Yoshinaga Transcription factors interactions: selectors of positive or negative regulation form a single DNA element Science 249 1990 1266 1272
38. J. Corren Intranasal corticosteroids for allergic rhinitis: how do different agents compare? J Allergy Clin Immunol 104 1999 S144 S149
39. E. Minshall, O. Ghaffar, and L. Cameron Assessment by nasal biopsy of long-term use of monetasone furoate nasal spray (Nasonex) in the treatment of perennial rhinitis Otolaryngol Head Neck Surg 118 1998 648 654
40. A.F. Holm, W.J. Fokkens, and T. Godthelp A 1-yr placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study Clin Otolaryngol 23 1998 69 73
41. A.M. Wilson, L.C. McFarlane, and B.J. Lipworth Effect of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measurements of hypothalamic-pituitary-adrenal axis activity J Allergy Clin Immunol 101 1998 470 474
42. A.M. Wilson, E.J. Sims, and L.C. McFarlane Effects of intranasal corticosteroids on adrenal, bone, and blood markers of systemic activity in allergic rhinitis J Allergy Clin Immunol 102 1998 598 604
43. S. Suissa, M. Baltzan, and R. Kremer Inhaled and nasal corticosteroid use and the risk of fracture Am J Respir Crit Care Med 169 1 2004 83 88
44. P. Van Cauwenberge, and E.F. Juniper Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis Clin Exp Allergy 30 2000 891 899
45. F.E.R. Simons, and K.J. Simons Clinical pharmacology of H1-antihistamines F.E.R. Simons Histamine and H1-antihistamines in allergic disease 2nd edition 2002 Marcel Dekker New York 141 178
46. G. Passalacqua, A. Scordamaglia, and S. Ruffoni Sedation from H1 antagonists: evaluation methods and experimental results Allergol Immunopathol (Madr) 21 1993 79 83
47. J.W. Soper, A.K. Chaturvedi, and D.V. Canfield Prevalence of chlorpheniramine in aviation accident pilot fatalities, 1991-1996 Aviat Space Environ Med 71 2000 1206 1209
48. T.M. Gilmore, B.H. Alexander, and B.A. Mueller Occupational injuries and medication use Am J Ind Med 30 2 1996 234 239
49. I.M. Cockburn, H.L. Bailit, and E.R. Berndt Loss of work productivity due to illness and medical treatment J Occup Environ Med 41 1999 948 953
50. J.M. Weiler, J.R. Bloomfield, and G.G. Woodworth Effects of fexofenadine, diphenhydramine, and alcohol on driving performance: a randomized, placebo-controlled trial in the Iowa Driving Simulator Ann Intern Med 132 2000 354 363
51. D.W. Goetz, J.M. Jacobson, and J.E. Murnane Prolongation of simple and choice reaction times in a double-blinded comparison of twice-daily hydroxyzine versus terfenadine J Allergy Clin Immunol 84 1989 316 322
52. 1-antihistamines N.F. Adkinson Jr. J.W. Yunginger W.W. Busse Middleton's allergy: principles and practice 6th edition 2003 Mosby Philadelphia 834 869
53. G.S. Richardson, T.A. Roehrs, and L. Rosenthal Tolerance to daytime sedative effects of H1 antihistamines J Clin Psychopharmacol 22 5 2002 511 515
54. Zyrtec [prescribing information]. New York: Pfizer Laboratories; updated 2004. Available at: http://www.zyrtec.com. Accessed February 23, 2005.
55. H.M. Druce, W.R. Thoden, and P. Mure Brompheniramine, Loratadine and placebo in allergic rhinitis: a placebo-controlled comparative clinical trial J Clin Pharmacol 38 1998 382 389
56. M. Shinoda, N. Watanabe, and T. Suko Effects of anti-allergic drugs on substance P (SP) and vasoactive intestinal peptide (VIP) in nasal secretions Am J Rhinol 11 3 1997 237 241
57. Y. Hamasaki, M. Shafigeh, and S. Yamamoto Inhibition of leukotriene synthesis by azelastine Ann Allergy Asthma Immunol 76 5 1996 469 475
58. K. Yoneda, T. Yamamoto, and E. Ueta Suppression by azelastine hydrochloride of NF-kappa B activation involved in generation of cytokines and nitric oxide Jpn J Pharmacol 73 2 1997 145 153
59. W.W. Storms, D.S. Pearlman, and P. Chervinsky Effectiveness of azelastine nasal solution in seasonal allergic rhinitis Ear Nose Throat J 73 6 1994 382 394
60. P.H. Ratner, S.R. Findlay, and F. Hampel Jr. A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis J Allergy Clin Immunol 94 5 1994 818 825
61. E.O. Meltzer, J.M. Weiler, and R.J. Dockhorn Azelastine nasal spray in the management of seasonal allergic rhinitis Ann Allergy 72 4 1994 354 359
62. C.H. Banov, and P. Lieberman Vasomotor Rhinitis Study Groups. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis Ann Allergy Asthma Immunol 86 1 2001 28 35
63. L. Malm, T.V. McCaffrey, and E.B. Kern Alpha-adrenoceptor-mediated secretion from the anterior nasal glands of the dog Acta Otolaryngol 96 1983 149 155
64. L. Malm, and A. Anggard Vasoconstrictors N. Mygind R.M. Naclerio Allergic and non-allergic rhinitis: clinical aspects 1993 Munsgaard Copenhagen (Denmark) 95 100
65. J.S.G. Cos Disodium cromoglycate (FPL 670 "Intal"): a specific inhibitor of reaginic antigen-antibody mechanisms Nature 216 1967 1328 1329
66. N.G.M. Orie, H. Booij-Nord, and Z. Pelikan Protective effect of disodium cromoglycate on nasal and bronchial reactions after allergen challenge J. Pepys A.W. Frankland Disodium cromoglycate in allergic airway disease 1970 Butterworth London 33 41
67. E.O. Meltzer NasalCrom Study Group. Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study Clin Ther 24 6 2002 942 952
68. R.H. Cohan, F.L. Bloom, and R.B. Rhoades Treatment of perennial allergic rhinitis with cromolyn sodium. Double-blind study on 34 adult patients J Allergy Clin Immunol 58 1 Pt 2 1976 121 128
69. D. Wang, P. Clement, and J. Smitz Concentrations of chemical mediators in nasal secretions after nasal allergen challenges in atopic patients Eur Arch Otorhinolaryngol 252 Suppl 1995 S40 S43
70. H. Bisgaard, P. Olsson, and M. Bende Effect of leukotriene D4 on nasal mucosal blood flow, nasal airway resistance and nasal secretions in humans Clin Allergy 16 1986 289 297
71. M. Fujita, Y. Yonetomi, and K. Shimouchi Involvement of cysteinyl leukotrienes in biphasic increase of nasal airway resistance of antigen-induced rhinitis in guinea pigs Eur J Pharmacol 369 3 1999 349 356
72. K.A. McGill, and W.W. Busse Zileuton Lancet 348 1996 519 2419
73. S.E. Wenzel, J.B. Trudeau, and D.A. Kaminsky Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma Am J Respir Crit Care Med 152 1995 897 905
74. M.C. Liu, L.M. Dube, and J. Lancaster Acute and chronic effects of a %-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial J Allergy Clin Immunol 98 1996 859 871
75. H.R. Knapp Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor N Engl J Med 323 25 1990 1745 1748
76. T. Pullerits, L. Praks, and B.E. Skoogh Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis Am J Respir Crit Care Med 159 6 1999 1814 1818
77. J. Corren, S. Spector, and L. Fuller Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure Ann Allergy Asthma Immunol 87 3 2001 211 217
78. W. Phipatanakul, P.A. Eggleston, and M.K. Conover-Walker A randomized, double-blind, placebo-controlled trial of the effect of zafirlukast on upper and lower respiratory responses to cat challenge J Allergy Clin Immunol 105 4 2000 704 710
79. G. Philip, K. Malmstrom, and F.C. Hampel Montelukast Spring Rhinitis Study Group. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring Clin Exp Allergy 32 7 2002 1020 1028
80. J. van Adelsberg, G. Philip, and A.J. Pedinoff Montelukast Fall Rhinitis Study Group. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period Allergy 58 12 2003 1268 1276
81. P. Chervinsky, G. Philip, and M.P. Malice Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies Ann Allergy Asthma Immunol 92 3 2004 367 373
82. E.O. Meltzer, K. Malmstrom, and S. Lu Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial J Allergy Clin Immunol 105 5 2000 917 922
83. A.M. Wilson, L.C. Orr, and W.J. Coutie A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis Clin Exp Allergy 32 1 2002 126 132
84. P.H. Ratner, W.C. Howland 3rd, and R. Arastu Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast Ann Allergy Asthma Immunol 90 5 2003 536 542
85. T.B. Casale Anti-IgE (Omalizumab) therapy in seasonal allergic rhinitis Am J Respir Crit Care Med 164 2001 S18 S21
86. E. Adelroth, S. Rak, and T. Huahtela Recombinant humanized mAb-E25, an anti IgE mAb, in birch pollen-induced seasonal allergic rhinitis J Allergy Clin Immunol 106 2000 253 259
87. P. Chervinsky, T. Casale, and R. Townley Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis Ann Allergy Asthma Immunol 91 2 2003 160 167
88. A.M. Vignola, M. Humbert, and J. Bousquet Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR Allergy 59 7 2004 709 717
89. J. Corren, D. Diaz-Sanchez, and A. Saxon Effects of omalizumab, a humanized monoclonal anti IgE antibody, on nasal reactivity to allergen and local IgE synthesis Ann Allergy Asthma Immunol 93 3 2004 243 248
90. S.J. Till, J.N. Francis, and K. Nouri-Aria Mechanisms of immunotherapy J Allergy Clin Immunol 113 6 2004 1025 1034
91. Joint Task Force on Practice Parameters Allergen immunotherapy: a practice parameter. American Academy of Allergy, Asthma and Immunology. American College of Allergy, Asthma and Immunology Ann Allergy Asthma Immunol 90 1 Suppl. 1 2003 1 40
92. S.R. Durham, S.M. Walker, and E.M. Varga Long-term clinical efficacy of grass-pollen immunotherapy N Engl J Med 341 7 1999 468 475
93. S.M. Walker, G.B. Pajno, and M.T. Lima Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial J Allergy Clin Immunol 107 1 2001 87 93
94. V.A. Varney, K. Tabbah, and G. Mavroleon Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial Clin Exp Allergy 33 8 2003 1076 1082
95. C. Möller, S. Dreborg, and H.A. Ferdousi Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis J Allergy Clin Immunol 109 2002 251 256
96. D.I. Bernstein, M. Wanner, and L. Borish Immunotherapy Committee, American Academy of Allergy, Asthma and Immunology. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001 J Allergy Clin Immunol 113 6 2004 1129 1136
97. J.T. Li Immunotherapy for allergic rhinitis Immunol Allergy Clin North Am 20 2000 381 400